< Zurück zu den aktuellen Neuigkeiten & Events

Neuigkeiten

Montenegro to become the 39th member of the EPC

September 2022

From 1 October 2022 Montenegro will become a member state of the EPO.

European patent applications (including European Regional Phase applications derived from an International PCT application) which are filed on or after this date will automatically designate Montenegro in addition to 38 other countries. Any PCT application filed on or after 1 October 2022 will automatically include Montenegro for the purpose of obtaining a European patent. Up to and including 30 September 2022, an applicant has to specifically designate Montenegro by paying the Extension fee for this state. Nationals of Montenegro and persons having their principal place of business or residence in Montenegro will also be entitled from 1 October 2022 to file international applications with the EPO as receiving Office.

This is the first expansion of the EPO since 2010 when Serbia and Albania were admitted. The EPC has grown from 7 founding states in 1977 to what will be 39 states when Montenegro joins. Bosnia and Herzegovina will be the one remaining extension state. Among the validation states there are Morocco, Tunisia, Moldova, and Cambodia. Georgia is reportedly set to become a validation state in the near future.


This update was prepared by HGF Professional Standards Officer Dr Edward Pullicino.

Aktuelle Neuigkeiten

Event - 11. November 2025

OIS Investor Forum - Jeffries

HGF is proud to be sponsoring the OIS Investor Forum on 18th November. One of the premier gatherings for leaders, innovators, and investors across the healthcare industry. The forum covers …

Veranstaltungsdetails

From Stripes to Supermarkets: The Court of Appeal Reaffirms the Need for Precision in Trade Mark Law

On 23 October 2025, Lord Justice Arnold delivered two landmark Court of Appeal decisions addressing trade mark registrability: Thom Browne Inc & Anor v adidas AG [2025] EWCA Civ 1340 …

Weiterlesen

Protecting Digital Health innovation in the AI revolution

As artificial intelligence (AI) continues to transform healthcare, from diagnostic imaging and drug discovery to wearable devices and clinical decision support, questions around how to protect these advancements have become …

Weiterlesen

Doubling Up on Added Matter at the UPC

Following the UPC Court of Appeal (CoA) decision in Abbott v Sibio (APL_39664/2024, 14 February 2025) we now have a second CoA decision on added matter in expert Klein v …

Weiterlesen
Event - 4. November 2025

HGF are Silver Sponsors of LSPN Europe 2025

HGF is proud to be a Silver Sponsor of LSPN Europe 2025, a leading forum dedicated to helping life sciences innovators protect and leverage their intellectual property across the entire …

Veranstaltungsdetails
Event - 30. bis 31. Oktober 2025

RAPS European Digital Technologies and Software conference

HGF is proud to be attending the RAPS European Digital Technologies and Software conference in The Netherlands on 30th-31st October. HGF Partner and Patent Attorney Janine Swarbrick and Patent Director …

Veranstaltungsdetails

Protect It Before You Promote It: IP Advice for MedTech Innovators

Developed a new medical product? Check. Got tickets to an exciting MedTech conference to show off your new product? Check. Intellectual property? Pardon? In the excitement of bringing a new …

Weiterlesen

Agritech Thymes: Die Gefahr der stillschweigenden Zustimmung: Lehren aus dem Fall „Pink Lady“

Kann die Lieferung einer Pflanzensorte ohne klare und definierte Nutzungsbeschränkungen als stillschweigende Zustimmung zu ihrer Vermarktung angesehen werden? Im Mittelpunkt dieses Falls stehen die Beweise, die erforderlich sind, um „ernsthafte …

Weiterlesen